SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 33.53-2.8%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (17048)7/11/2004 1:11:13 PM
From: Bluegreen  Read Replies (1) of 17367
 
Bob, I say this in all seriousness. Xoma COULD be becoming a situation of last man out. I don't see ANYTHING standing in Xoma's way to restructure AFTER Castello's sell program goes through. Raptiva's sales are pitiful and Xoma's burn rate is HUGE and remember the DEBT owed to Genentech. Remember in a restructure shares of Xoma could become WORTHLESS!!! In my opinion I think Xoma is a GREAT short at these weak levels, Raptiva poor sales, Genentech ALWAYS bashing Raptiva in regards to competition on conference calls, future indications(reminds me of Neuprex with Baxter),Xoma's HUGE burn rate and last but not least HUGE debt to Genentech. Once again in my opinion I think a restructure is a possibility.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext